|
|||||
|
|
A Phase 1b,Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis |
|
| Authors: | Stephen C. Piscitelli Ana B. Pavel Kimberly McHale John E. Jett Jon Collins Dawn Gillmor Glenn Tabolt Randall Li Teresa Song Ning Zhang Anna M. Tallman Emma Guttman-Yassky |
| Affiliation: | 1. Dermavant Sciences, Inc, Durham, North Carolina, USA;2. Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA;3. Department of Biomedical Engineering, The University of Mississippi, Oxford, Mississippi, USA;4. Immunovant, Inc, Durham, North Carolina, USA;5. Enzyvant, Inc, Durham, North Carolina, USA;6. Dermavant Sciences, Inc, New York, New York, USA |
| Abstract: | |
| Keywords: | AD" },{" #name" :" keyword" ," $" :{" id" :" kwrd0015" }," $$" :[{" #name" :" text" ," _" :" atopic dermatitis EASI" },{" #name" :" keyword" ," $" :{" id" :" kwrd0025" }," $$" :[{" #name" :" text" ," _" :" Eczema Area and Severity Index LS" },{" #name" :" keyword" ," $" :{" id" :" kwrd0035" }," $$" :[{" #name" :" text" ," _" :" lesional Th" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" T helper type |
| 本文献已被 ScienceDirect 等数据库收录！ | |